Tonight on Nightly Business Report, Amgen spends more than $10b to buy Onyx Pharmaceuticals giving it access to the fast-growing market for cancer drugs. Is this the start of a wave of biotech deals?
And, NBR will tell you why a growing number of parents are struggling to pay off not only their own college loans, but also their children’s.
About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Capitol Police probing claims GOP lawmakers gave tours to Trump supporters before riot
- Health Secretary Azar tells Trump U.S. Capitol attack was assault on democracy that tarnishes legacy
- These entrepreneurs want a second PPP loan. What you should know if you're applying for more money
- 'I don’t see anything on the horizon that can stop the growth of the ETF market,' Invesco official says. Here are her 2021 predictions
- Apple CEO Tim Cook's new cash bonus sweetener not tied to bigger sales or profits
NBR on TwitterMy Tweets
Subscribe to RSS